Guess Says Raising Full-Year Outlook For Operating Margin To 10%, Says Increases Share Repurchase Authorization To $200M

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 21.24% on an annualized basis producing an average annual return of 27.82%. Currently, Regeneron Pharmaceuticals has a market capitalization of $81.63 billion.